Loading clinical trials...
Loading clinical trials...
Treatments Against RA and Effect on FDG-PET/CT (The TARGET Trial)
Conditions
Interventions
Methotrexate
Sulfasalazine
+3 more
Locations
31
United States
University of Alabama at Birmingham
Birmingham, Alabama, United States
Loma Linda University Clinical Trial Center
Loma Linda, California, United States
David Geffen School of Medicine at UCLA
Los Angeles, California, United States
Brigid Freyne, MD Inc.
Murrieta, California, United States
Desert Medical Advances
Palm Desert, California, United States
University of California San Francisco
San Francisco, California, United States
Start Date
July 1, 2016
Primary Completion Date
May 1, 2021
Completion Date
May 1, 2021
Last Updated
October 26, 2022
NCT05961592
NCT07017686
NCT05038553
NCT05790356
NCT05657847
NCT03429426
Lead Sponsor
Brigham and Women's Hospital
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions